Form 4: Pacira BioSciences Director Acquires Stock Options and Restricted Stock Units
SEC Form 4 Filing
Michael J. Yang, a director at Pacira BioSciences, acquired stock options and restricted stock units on June 12, 2024.
Summary
- On June 12, 2024, Michael J. Yang, a director of Pacira BioSciences, acquired 5,230 shares of common stock and 12,179 stock options.
- The stock options have an exercise price of $28.68 and expire between June 12, 2025, and June 12, 2034.
- The 5,230 shares represent restricted stock units that vest on June 12, 2025, contingent upon continuous service with Pacira BioSciences.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. Insider buying can be interpreted as a sign of confidence, but it's a routine transaction.
Positives
- The acquisition of stock options and restricted stock units by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely monitored by investors to gauge sentiment and potential future actions of key personnel.
Stakeholder Impact
- The acquisition of shares and options by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of transaction: Acquisition of stock options and restricted stock units. |
| 06/12/2025 | Vesting date for the restricted stock units. |
| 06/12/2025 06/12/2034 | Expiration date range for the acquired stock options. |
| 06/13/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.